Activin Pathway Inhibition and Rapid Progression of Malignancy in Pulmonary Arterial Hypertension: A Case Series and Hypothesis. (PubMed, Respir Med) - Sep 12, 2026 - "We describe a series of malignancies that occurred in patients treated with sotatercept. While these cases do not establish causality, they highlight the need for vigilance and further study."
Journal • Cardiovascular • Hypertension • Oncology • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases
|
|
Adriano R Tonelli; Jana Berro; Kristin B Highland; Kulwant S Aulak
|